Home Compare LIN vs NSIS-B.CO
Stock Comparison · Industry comparison · Specialty Chemicals

Linde vs Novozymes A/S: Which Stock Looks Stronger in 2026?

Linde holds the cleaner structural position, with profitability as the main driver and growth adding further support. Novozymes A/S still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Linde holds the more constructive position. That puts structure and market broadly in agreement — Linde's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (LIN: Nasdaq 100, NSIS-B.CO: STOXX 600).

Updated 2026-05-17

Profitability remains the main source of distance in the comparison. The overall score gap is 13 points in favour of Linde plc.

INDUSTRY COMPARISON

Both operate in: Specialty Chemicals

This comparison is based on industry proximity, not on functional trajectory similarity. LIN and NSIS-B.CO share the same industry classification.

For a similarity-based comparison, see how Linde and Novozymes A/S each position within their functional peer groups in AssetNext.

Peer-Relative Score
LIN
Linde plc
68
Peer-Score
Signal qualitylow
Peer basis: Nasdaq 100
vs
NSIS-B.CO
Novozymes A/S
55
Peer-Score
Signal qualityHigh
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: LIN vs NSIS-B.CO Profitability 68 27 Stability 82 80 Valuation 58 39 Growth 67 95 LIN NSIS-B.CO
Gap Ranking
#1 Profitability +41
#2 Growth +28
#3 Valuation +19
#4 Stability +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for LIN and NSIS-B.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer LINNSIS-B.CO Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Novozymes A/S.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where LIN and NSIS-B.CO each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY LIN Elevated · near norm 0th 50th 100th 67 pct gap NSIS-B.CO Neutral · below norm 0th 50th 100th 99th 32nd
Today NSIS-B.CO sits in the lower-middle of its own 5-year history (32nd percentile), while LIN sits higher in its own history (99th). Within each stock's own 5-year context, NSIS-B.CO is at a historically more favourable entry position than LIN. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
On profitability, Linde plc ranks near the top of the group; Novozymes A/S sits in the weaker half.
Growth
On growth, the edge still sits with Novozymes A/S, even though both profiles look solid.
Profitability — Dominant Gap
LIN
68
NSIS-B.CO
27
Gap+41in favour of LIN

Capital efficiency adds support, with a 11.2-point ROIC advantage.

What keeps the gap from being one-sided

Growth still leans toward Novozymes A/S, so the lead is real without reading as one-way.

What this means for the comparison

Profitability settles the comparison, while pricing and growth keep the broader setup from looking fully aligned.

Explore full peer positioning in AssetNext

Break down the LIN vs NSIS-B.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how LIN and NSIS-B.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.